Abstract The 2021 WHO Classification of Thoracic Tumours was published earlier this year,
with classification of lung tumors being one of the chapters. The principles remain those of …

Significant progress has been made in the understanding of lung cancer biology, due in
large part to advancement in the understanding of tumor biology and pathogenesis …

The classification of neuroendocrine neoplasms (NENs) differs between organ systems and
currently causes considerable confusion. A uniform classification framework for NENs at any …

ABSTRACT Background Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity
of randomized studies, this expert consensus document represents an initiative by the …

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung
Cancer (SCLC) provide recommended management for patients with SCLC, including …

The latest World Health Organization (WHO) classification from 2015 has grouped lung and
thymic neuroendocrine tumours (NETs)(named neoplasm in the digestive WHO …

Purpose: Previous genomic studies have identified two mutually exclusive molecular
subtypes of large-cell neuroendocrine carcinoma (LCNEC): the RB1 mutated (mostly …

Next‐generation sequencing (NGS) was applied to 148 lung neuroendocrine tumours
(LNETs) comprising the four World Health Organization classification categories: 53 typical …

Neuroendocrine tumors have shown rising incidence mainly due to higher clinical
awareness and better diagnostic tools over the last 30 years. Functional imaging of …

Classification of lung neuroendocrine (NE) tumors is a step-wise process with four tumor
categories being identified by morphology, namely typical carcinoid (TC), atypical carcinoid …